Drugs Control Media Services - Drugscontrol
Welcome to DrugsControl Media Services, DrugsControl Media Services is India's leading independent Drug Regulatory Resource Portal. Our platform provides up-to-date information on pharmaceutical regulations and compliance requirements, serving as a valuable resource for industry professionals and companies in the pharmaceutical sector. With a comprehensive database of drug-related news ...
Proposed Schedule M guidelines will have provisions for prompt ...
Mumbai, 20 Nov 2023: The proposed Revised Schedule M guidelines will have provisions for a comprehensive system towards prompt and effective drug recall. It will have provisions to inform the licensing authority about the product or drug recall, said Dr. S Eswara Reddy, joint drugs controller, Central Drugs Standard ...
DCGI directs all state & UT drugs controllers to implement ONDLS …
Mar 1, 2022 · News Detail. DCGI directs all state & UT drugs controllers to implement ONDLS portal (03-01-2022) Mumbai, 3 Jan 2022: In a bid to facilitate ease of doing business, the Drugs Controller General of India (DCGI) has directed all state and Union territory drugs controllers to adopt Online National Drugs Licensing System (ONDLS) portal for issuance ...
MDC recommends prices of anti-diabetic drugs with off patented ...
New Delhi, 8 June 2023: The Multidisciplinary Committee (MDC) of Experts has recommended the prices of various fixed dose combinations (FDCs) containing dapagliflozin, sitagliptin, vildagliptin, pioglitazone, among others in tune with the recent amendments made by the Department of Pharmaceuticals (DoP) in the Drugs (Prices …
DrugsControl Media Services
New Delhi, 31 July 2024: The Central drug regulator, the Central Drugs Standard Control Organisation (CDSCO) has decided to accept the preclinical toxicity data already generated and accepted by regulatory authorities of other countries for review of new drugs, subsequent new drugs (SNDs) and fixed dose combinations (FDCs), subject ...
DrugsControl Media Services
Mumbai, 22 Jan 2021: In order to streamline the process of import registration of cosmetics, the Central Drugs Standard Control Organisation (CDSCO) has issued frequently asked questions (FAQs) and guidance document for grant or retention of registration certificate (RC) or license for import or manufacture of cosmetics in India ...
DCGI frames guidelines to ensure product traceability
Oct 11, 2024 · New Delhi, 12 Aug 2024: The Drugs Controller General of India (DCGI), the country's top drug regulator, has framed standard operating procedure and guidelines to ensure product traceability throughout the supply chain, as the menace of fake and spurious medicines grows. View Details.
Docs who take payments more likely to prescribe inappropriate …
New York, 25 Oct 2023: Oncologists who receive payments from industry may be more likely to prescribe nonrecommended and lowvalue treatments. That is the assertion of a paper published in The BMJ that analyzed data on claims and physician payments ...
Centre to launch national portal for online drug sale
NEW DELHI 11 AUG 2023: In a bid to check the illegal sale of prescription drugs by e-pharmacies and e-commerce platforms and to address the potential dangers such as data misuse the Centre plans to launch a national portal for online sale of medicines a top government official told this newspaper. The portal will be authentic and safe and no ...
CDSCO declares 42 drug samples as NSQ out of 1227 tested in Sept
Oct 19, 2021 · CDSCO declares 42 drug samples as NSQ out of 1227 tested in Sept (19-10-2021) New Delhi, 19 Oct 2021: The Central Drugs Standard Control Organisation (CDSCO) has declared 42 drug samples as not of standard quality (NSQ) out of the 1227 it has tested for the month of September. One sample was declared as misbranded, during the month. View Details.
- Some results have been removed